You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2024

Actavis Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS, and what generic and branded alternatives to ACTAVIS drugs are available?

ACTAVIS has three hundred and twenty-five approved drugs.

There are twenty tentative approvals on ACTAVIS drugs.

Summary for Actavis

US Patents:	0
Tradenames:	229
Ingredients:	218
NDAs:	325
Patent Litigation for Actavis:	See patent lawsuits for Actavis
PTAB Cases with Actavis as petitioner:	See PTAB cases with Actavis as petitioner

Drugs and US Patents for Actavis

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Totowa	FLUDARABINE PHOSPHATE	fludarabine phosphate	INJECTABLE;INJECTION	078610-001	Feb 11, 2009	AP	RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Actavis Labs Fl Inc	RAMELTEON	ramelteon	TABLET;ORAL	091610-001	Aug 19, 2015	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Elizabeth	MIRTAZAPINE	mirtazapine	TABLET, ORALLY DISINTEGRATING;ORAL	077959-002	Feb 14, 2011		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Labs Fl Inc	PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE	phentermine hydrochloride; topiramate	CAPSULE, EXTENDED RELEASE;ORAL	204982-003	Jun 25, 2024	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Mid Atlantic	BETAMETHASONE DIPROPIONATE	betamethasone dipropionate	OINTMENT;TOPICAL	071012-001	Feb 3, 1987	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Actavis

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Actavis Labs Ut Inc	LOXITANE IM	loxapine hydrochloride	INJECTABLE;INJECTION	018039-001	Approved Prior to Jan 1, 1982	3,546,226	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ACTAVIS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.